Source comparison
Thymosin Alpha-1 Vial Size Comparison
2mg 4 doses 8 doses 1mL $15–18 28 days Pilot studies, single-subject trials, dose-finding experiments Minimal waste, high per-mg cost—use when protocol scope is uncertain or timeline is under 2 weeks 5mg 10 doses 20 doses 1–2mL $12–15 Standard 2–4 week protoco
This comparison does not assign a generated winner or score.
- 2mg
- 4 doses
- 8 doses
- 1mL
- $15–18
- 28 days
- Pilot studies, single-subject trials, dose-finding experiments
- Minimal waste, high per-mg cost—use when protocol scope is uncertain or timeline is under 2 weeks
- 5mg
- 10 doses
- 20 doses
- 1–2mL
- $12–15
- Standard 2–4 week protocols, single-subject studies
- Balances cost and flexibility—our most commonly recommended size for new protocols
- 10mg
- 40 doses
- 2mL
- $10–12
- 4–6 week protocols, 2–4 concurrent subjects
- Optimal cost-efficiency for most research applications without forcing waste
- 20mg
- 80 doses
- 4mL
- $8–10
- 28 days (split into two 2mL vials recommended)
- Multi-subject studies, back-to-back protocols, high-frequency dosing regimens
- Cost-effective if peptide consumption exceeds 15mg in 28 days—otherwise risk significant waste
- 50mg
- 100 doses
- 200 doses
- Split into 5×2mL
- $6–8
- 28 days per reconstituted aliquot
- Large-scale studies, continuous-use labs, collaborative pooled orders
- Only viable if lab uses 40+ mg per month consistently—otherwise per-dose cost exceeds smaller vials due to degradation loss